Naoki Isogawa

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Therapeutic innovation & regulatory science

Pain management

Osaka University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Osaka University

Japan

PHD :: Statistics

Publications

Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo
Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki Isogawa. Therapeutic innovation & regulatory science (2024)
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo
Performance Evaluation of Interim Analysis in Bioequivalence Studies. Therapeutic innovation & regulatory science (2024)
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo
Performance Evaluation of Interim Analysis in Bioequivalence Studies. Therapeutic innovation & regulatory science (2024)
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo
Performance Evaluation of Interim Analysis in Bioequivalence Studies. Therapeutic innovation & regulatory science (2024)
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo
Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki Isogawa. Therapeutic innovation & regulatory science (2024)
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo
Performance Evaluation of Interim Analysis in Bioequivalence Studies. Therapeutic innovation & regulatory science 58 (5) (2024)
Shin-Ichi Konno, Takuya Nikaido, John D Markman, Makoto Ohta, Toshiya Machida, Naoki Isogawa, Hiroki Yoshimatsu, Lars Viktrup, Mark T Brown, Christine R West, Kenneth M Verburg
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study. Pain management (2021)
Naoki Isogawa, Kentaro Takeda, Kazushi Maruo, Takashi Daimon
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints. Therapeutic innovation & regulatory science 54 (3) (2020)
Naoki Isogawa, Kentaro Takeda, Kazushi Maruo, Takashi Daimon
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints. Therapeutic innovation & regulatory science (2019)

Naoki Isogawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naoki Isogawa